| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KRT2 KRT6A KRT6B TUBA3D TUBA1C MYBPC3 | 7.95e-09 | 130 | 201 | 12 | GO:0005200 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBA3E GIMAP1 STING1 TUBA8 TUBA4A TUBA3C TUBA1B SEPTIN3 TUBA1A GPSM2 SEPTIN4 TUBA3D TUBA1C ATL1 ARHGDIB | 4.07e-05 | 439 | 201 | 15 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBA3E GIMAP1 STING1 TUBA8 TUBA4A TUBA3C TUBA1B SEPTIN3 TUBA1A GPSM2 SEPTIN4 TUBA3D TUBA1C ATL1 ARHGDIB | 4.07e-05 | 439 | 201 | 15 | GO:0019001 |
| GeneOntologyCellularComponent | endosome | RIPK1 STING1 GH2 JAK2 MAGI2 SAMD9L TUBA1A BIN1 FOLR1 KIF16B GRIA1 ASB15 S1PR1 TRIM3 CPTP CD1C AP4S1 EGFR CD22 LNPEP SBF2 GIGYF2 PRKCI TNFAIP1 KIF13A PACSIN2 EPHB1 | 2.52e-05 | 1167 | 203 | 27 | GO:0005768 |
| GeneOntologyCellularComponent | membrane raft | PRSS8 MYO1A HPSE JAK2 TUBA1B TUBA1A VDR TUBA1C DLL1 S1PR1 EGFR PACSIN2 EPHB1 | 5.70e-05 | 362 | 203 | 13 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | PRSS8 MYO1A HPSE JAK2 TUBA1B TUBA1A VDR TUBA1C DLL1 S1PR1 EGFR PACSIN2 EPHB1 | 6.03e-05 | 364 | 203 | 13 | GO:0098857 |
| GeneOntologyCellularComponent | supramolecular fiber | CASP14 MYO1A TUBA3E HAUS3 TUBA8 EFHB TUBA4A TUBA3C TUBA1B KRT6C TUBA1A ASPM KRT2 FLNB KRT6A KRT6B BIN1 TUBA3D TUBA1C KIF16B APC LRPPRC MYH14 TRIM32 KIF13A MYBPC3 | 7.99e-05 | 1179 | 203 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CASP14 MYO1A TUBA3E HAUS3 TUBA8 EFHB TUBA4A TUBA3C TUBA1B KRT6C TUBA1A ASPM KRT2 FLNB KRT6A KRT6B BIN1 TUBA3D TUBA1C KIF16B APC LRPPRC MYH14 TRIM32 KIF13A MYBPC3 | 8.91e-05 | 1187 | 203 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CASP14 MYO1A TUBA3E HAUS3 TUBA8 EFHB TUBA4A TUBA3C TUBA1B KRT6C TUBA1A ASPM KRT2 KRT6A KRT6B TUBA3D TUBA1C KIF16B APC LRPPRC KIF13A | 1.87e-04 | 899 | 203 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule | TUBA3E HAUS3 TUBA8 EFHB TUBA4A TUBA3C TUBA1B TUBA1A ASPM TUBA3D TUBA1C KIF16B APC LRPPRC KIF13A | 2.35e-04 | 533 | 203 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 5.56e-04 | 4 | 203 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | endosome lumen | 7.92e-04 | 43 | 203 | 4 | GO:0031904 | |
| Domain | Alpha_tubulin | 5.32e-13 | 9 | 201 | 7 | IPR002452 | |
| Domain | Tubulin_C | 2.24e-09 | 22 | 201 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.24e-09 | 22 | 201 | 7 | IPR018316 | |
| Domain | Tubulin_C | 2.24e-09 | 22 | 201 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 3.19e-09 | 23 | 201 | 7 | IPR008280 | |
| Domain | Tubulin_C | 3.19e-09 | 23 | 201 | 7 | IPR023123 | |
| Domain | TUBULIN | 3.19e-09 | 23 | 201 | 7 | PS00227 | |
| Domain | Tubulin | 3.19e-09 | 23 | 201 | 7 | IPR000217 | |
| Domain | Tubulin | 3.19e-09 | 23 | 201 | 7 | SM00864 | |
| Domain | Tubulin_CS | 3.19e-09 | 23 | 201 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 4.46e-09 | 24 | 201 | 7 | IPR003008 | |
| Domain | Tubulin | 4.46e-09 | 24 | 201 | 7 | PF00091 | |
| Domain | - | 4.93e-08 | 20 | 201 | 6 | 3.30.1330.20 | |
| Domain | - | 6.84e-08 | 21 | 201 | 6 | 1.10.287.600 | |
| Domain | - | 9.32e-08 | 22 | 201 | 6 | 3.40.50.1440 | |
| Domain | - | TTC21A GPSM2 TTC5 KDM6A CNOT10 TRAPPC8 LRPPRC MTOR IFT122 CDC23 LRP2BP | 1.56e-05 | 207 | 201 | 11 | 1.25.40.10 |
| Domain | TPR-like_helical_dom | TTC21A GPSM2 TTC5 KDM6A CNOT10 TRAPPC8 LRPPRC MTOR IFT122 CDC23 LRP2BP | 4.63e-05 | 233 | 201 | 11 | IPR011990 |
| Domain | Pkinase_Tyr | 7.85e-05 | 129 | 201 | 8 | PF07714 | |
| Domain | Keratin_2_head | 1.17e-04 | 24 | 201 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.17e-04 | 24 | 201 | 4 | PF16208 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.26e-04 | 138 | 201 | 8 | IPR001245 | |
| Domain | Keratin_II | 1.62e-04 | 26 | 201 | 4 | IPR003054 | |
| Domain | Peptidase_M1_N | 3.24e-04 | 13 | 201 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 3.24e-04 | 13 | 201 | 3 | PF01433 | |
| Domain | Tyr_kinase_cat_dom | 3.76e-04 | 88 | 201 | 6 | IPR020635 | |
| Domain | TyrKc | 3.76e-04 | 88 | 201 | 6 | SM00219 | |
| Domain | uDENN | 4.10e-04 | 14 | 201 | 3 | SM00800 | |
| Domain | TPR_1 | 4.24e-04 | 90 | 201 | 6 | IPR001440 | |
| Domain | TPR_1 | 4.24e-04 | 90 | 201 | 6 | PF00515 | |
| Domain | uDENN | 5.08e-04 | 15 | 201 | 3 | PF03456 | |
| Domain | TPR_repeat | 5.97e-04 | 133 | 201 | 7 | IPR019734 | |
| Domain | Post-SET_dom | 6.20e-04 | 16 | 201 | 3 | IPR003616 | |
| Domain | DENN | 6.20e-04 | 16 | 201 | 3 | SM00799 | |
| Domain | PostSET | 6.20e-04 | 16 | 201 | 3 | SM00508 | |
| Domain | DENN | 6.20e-04 | 16 | 201 | 3 | PF02141 | |
| Domain | dDENN | 6.20e-04 | 16 | 201 | 3 | PF03455 | |
| Domain | UDENN | 6.20e-04 | 16 | 201 | 3 | PS50946 | |
| Domain | DDENN | 6.20e-04 | 16 | 201 | 3 | PS50947 | |
| Domain | dDENN | 6.20e-04 | 16 | 201 | 3 | SM00801 | |
| Domain | dDENN_dom | 6.20e-04 | 16 | 201 | 3 | IPR005112 | |
| Domain | uDENN_dom | 6.20e-04 | 16 | 201 | 3 | IPR005113 | |
| Domain | DENN | 6.20e-04 | 16 | 201 | 3 | PS50211 | |
| Domain | DENN_dom | 6.20e-04 | 16 | 201 | 3 | IPR001194 | |
| Domain | POST_SET | 6.20e-04 | 16 | 201 | 3 | PS50868 | |
| Domain | PROTEIN_KINASE_TYR | 6.32e-04 | 97 | 201 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.32e-04 | 97 | 201 | 6 | IPR008266 | |
| Domain | MAPKKKK | 6.82e-04 | 4 | 201 | 2 | IPR021160 | |
| Domain | AWS | 1.13e-03 | 5 | 201 | 2 | SM00570 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 1.13e-03 | 5 | 201 | 2 | IPR013821 | |
| Domain | AWS | 1.13e-03 | 5 | 201 | 2 | PS51215 | |
| Domain | AWS_dom | 1.13e-03 | 5 | 201 | 2 | IPR006560 | |
| Domain | K_chnl_volt-dep_KCNQ | 1.13e-03 | 5 | 201 | 2 | IPR003937 | |
| Domain | KCNQ_channel | 1.13e-03 | 5 | 201 | 2 | PF03520 | |
| Domain | P-loop_NTPase | MYO1G ATP6V1B1 MYO1A GIMAP1 MAGI2 SAMD9L SEPTIN3 ASPM DDX4 MPP1 SEPTIN4 KIF16B ATL1 DMC1 HNRNPUL2 MYH14 CHTF18 KIF13A NLRP4 | 2.07e-03 | 848 | 201 | 19 | IPR027417 |
| Domain | TPR_REGION | 2.09e-03 | 165 | 201 | 7 | PS50293 | |
| Domain | TPR | 2.09e-03 | 165 | 201 | 7 | PS50005 | |
| Domain | Kinase-like_dom | EPHB3 RIPK1 JAK2 MLKL CLK1 SYK FGFR3 AKT3 MAP4K3 EGFR MTOR MAP4K5 PRKCI EPHB1 | 2.27e-03 | 542 | 201 | 14 | IPR011009 |
| Domain | Myosin_TH1 | 2.34e-03 | 7 | 201 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 2.34e-03 | 7 | 201 | 2 | IPR010926 | |
| Domain | TH1 | 2.34e-03 | 7 | 201 | 2 | PS51757 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 9.24e-12 | 17 | 172 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.65e-11 | 18 | 172 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.81e-11 | 19 | 172 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.81e-11 | 19 | 172 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 4.64e-11 | 20 | 172 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 4.64e-11 | 20 | 172 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 7.42e-11 | 21 | 172 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.42e-11 | 21 | 172 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.15e-10 | 22 | 172 | 8 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | TUBA3E HAUS3 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 1.46e-10 | 33 | 172 | 9 | M47901 |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.75e-10 | 23 | 172 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.75e-10 | 23 | 172 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.75e-10 | 23 | 172 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.60e-10 | 24 | 172 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.60e-10 | 24 | 172 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.78e-10 | 25 | 172 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.78e-10 | 25 | 172 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 5.41e-10 | 26 | 172 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.41e-10 | 26 | 172 | 8 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.05e-09 | 28 | 172 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.44e-09 | 29 | 172 | 8 | M27948 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.42e-09 | 32 | 172 | 8 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 3.42e-09 | 32 | 172 | 8 | M29848 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 4.47e-09 | 33 | 172 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.42e-09 | 35 | 172 | 8 | M47774 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CAPZA1 | 1.36e-08 | 53 | 172 | 9 | M27651 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.49e-08 | 38 | 172 | 8 | M14981 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CAPZA1 | 2.64e-08 | 57 | 172 | 9 | M27251 |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.35e-08 | 17 | 172 | 6 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 4.21e-08 | 43 | 172 | 8 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.21e-08 | 43 | 172 | 8 | M47669 | |
| Pathway | REACTOME_KINESINS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C KIF16B | 4.89e-08 | 61 | 172 | 9 | M977 |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 5.09e-08 | 44 | 172 | 8 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 5.09e-08 | 44 | 172 | 8 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 6.12e-08 | 45 | 172 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.34e-08 | 46 | 172 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.23e-07 | 49 | 172 | 8 | M891 | |
| Pathway | KEGG_GAP_JUNCTION | TUBA3E TUBA8 TUBA4A TUBA3C ITPR2 TUBA1B TUBA1A TUBA3D TUBA1C EGFR | 1.39e-07 | 90 | 172 | 10 | M4013 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.70e-07 | 51 | 172 | 8 | M26972 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C LNPEP | 2.14e-07 | 72 | 172 | 9 | M26954 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.69e-07 | 54 | 172 | 8 | M27482 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 3.12e-07 | 55 | 172 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 3.60e-07 | 56 | 172 | 8 | M2333 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FOLR1 TUBA3D TUBA1C CAPZA1 | 4.56e-07 | 102 | 172 | 10 | M27648 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.24e-07 | 27 | 172 | 6 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.24e-07 | 27 | 172 | 6 | MM15549 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.14e-06 | 29 | 172 | 6 | MM15219 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | TUBA3E TUBA8 TUBA4A TUBA3C JAK2 TUBA1B TUBA1A DOCK1 TUBA3D TUBA1C CAPZA1 KIF16B | 1.14e-06 | 170 | 172 | 12 | M941 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.11e-06 | 32 | 172 | 6 | MM14730 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C GRIA1 | 2.13e-06 | 94 | 172 | 9 | M2843 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KCNQ3 TUBA3D TUBA1C EGFR | 2.22e-06 | 121 | 172 | 10 | M872 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.31e-06 | 71 | 172 | 8 | M39690 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA3E HAUS3 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 2.32e-06 | 95 | 172 | 9 | M6729 |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | TUBA3E DENND2D TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GNS AKT3 BIN1 FOLR1 TUBA3D TUBA1C CAPZA1 KIF16B GRIA1 TRAPPC8 MADD AP4S1 EGFR LNPEP SBF2 PACSIN2 | 2.49e-06 | 630 | 172 | 23 | M11480 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.00e-06 | 52 | 172 | 7 | MM15211 | |
| Pathway | REACTOME_PROTEIN_FOLDING | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C KIF13A | 3.02e-06 | 98 | 172 | 9 | M776 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FOLR1 TUBA3D TUBA1C CAPZA1 GRIA1 | 3.27e-06 | 156 | 172 | 11 | M27097 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 3.41e-06 | 20 | 172 | 5 | MM1383 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C KIF16B | 3.57e-06 | 100 | 172 | 9 | M27650 |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3E ATG2A TUBA8 TUBA4A TUBA3C ITPR2 TUBA1B TUBA1A AKT3 TUBA3D TUBA1C APC ATF6 MTOR | 3.84e-06 | 261 | 172 | 14 | M42565 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.88e-06 | 76 | 172 | 8 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.88e-06 | 76 | 172 | 8 | M27215 | |
| Pathway | REACTOME_AGGREPHAGY | 4.35e-06 | 36 | 172 | 6 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.14e-06 | 37 | 172 | 6 | MM15102 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.21e-06 | 79 | 172 | 8 | M27743 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CAPZA1 KIF16B | 5.58e-06 | 134 | 172 | 10 | M27751 |
| Pathway | REACTOME_KINESINS | 5.64e-06 | 57 | 172 | 7 | MM15714 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.21e-05 | 116 | 172 | 9 | MM15715 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.38e-05 | 90 | 172 | 8 | M29841 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.45e-05 | 44 | 172 | 6 | MM14606 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA8 TUBA4A TUBA3C NEDD4 TUBA1B TUBA1A FLNB TUBA3D TUBA1C | 1.60e-05 | 151 | 172 | 10 | M550 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FOLR1 TUBA3D TUBA1C CAPZA1 GRIA1 | 1.84e-05 | 187 | 172 | 11 | M961 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.85e-05 | 68 | 172 | 7 | MM14968 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.90e-05 | 94 | 172 | 8 | MM14515 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CAPZA1 | 2.36e-05 | 126 | 172 | 9 | M705 |
| Pathway | REACTOME_AUTOPHAGY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ATG4B TUBA1A TUBA3D TUBA1C MTOR | 2.38e-05 | 158 | 172 | 10 | M27935 |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | RPN1 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B NEU1 TUBA1A ST8SIA5 FOLR1 TUBA3D TUBA1C CAPZA1 GRIA1 | 2.42e-05 | 307 | 172 | 14 | M894 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.43e-05 | 48 | 172 | 6 | MM15353 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | TUBA3E DENND2D TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GNS AKT3 BIN1 FOLR1 TUBA3D TUBA1C CAPZA1 KIF16B GRIA1 TRAPPC8 MADD AP4S1 EGFR LNPEP SBF2 PACSIN2 | 2.45e-05 | 725 | 172 | 23 | M27507 |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E HAUS3 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A IFT80 TUBA3D TUBA1C IFT122 | 3.59e-05 | 201 | 172 | 11 | M27472 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.87e-05 | 52 | 172 | 6 | MM14949 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3E ATG2A TUBA8 TUBA4A TUBA3C ITPR2 TUBA1B TUBA1A AKT3 TUBA3D TUBA1C APC ATF6 MTOR | 4.67e-05 | 326 | 172 | 14 | M39379 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.84e-05 | 138 | 172 | 9 | MM15635 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 4.84e-05 | 138 | 172 | 9 | M29805 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | TUBA3E TUBA8 TUBA4A TUBA3C ITPR2 NEDD4 TUBA1B PTPRJ TUBA1A ASB8 SYK AKT3 LILRA3 TUBA3D TUBA1C CAPZA1 ASB15 CD1C RNF123 CD22 TRIM32 MTOR LNPEP CDC23 | 6.81e-05 | 828 | 172 | 24 | M1058 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB3 RPS17 TUBA3E TUBA8 TUBA4A DSCAML1 TUBA3C TUBA1B TUBA1A SRGAP3 KCNQ3 SEMA6A DOCK1 RASA1 TUBA3D TUBA1C EGFR MYH14 EPHB1 | 7.69e-05 | 575 | 172 | 19 | M29853 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB3 TUBA8 TUBA4A DSCAML1 TUBA1B TUBA1A DOCK1 RASA1 TUBA3D TUBA1C EGFR EPHB1 | 8.65e-05 | 261 | 172 | 12 | MM15676 |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 9.56e-05 | 8 | 172 | 3 | M47394 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.14e-04 | 90 | 172 | 7 | MM14979 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3E TUBA8 TUBA4A TUBA3C NEDD4 JAK2 TUBA1B TUBA1A FLNB TUBA3D TUBA1C TRIM3 | 1.32e-04 | 273 | 172 | 12 | M983 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB3 CASP14 TUBA8 TUBA4A DSCAML1 TUBA1B TUBA1A DOCK1 KRT2 KRT6A KRT6B AKT3 RASA1 TUBA3D TUBA1C EGFR EPHB1 | 1.39e-04 | 502 | 172 | 17 | MM14537 |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.42e-04 | 9 | 172 | 3 | M47481 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.50e-04 | 66 | 172 | 6 | MM17074 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | DLGAP1 KCNH7 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KCNJ3 KCNQ3 TUBA3D TUBA1C GRIA1 SLC18A2 KCNQ4 | 1.56e-04 | 411 | 172 | 15 | M735 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.63e-04 | 127 | 172 | 8 | M27181 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.66e-04 | 162 | 172 | 9 | M29804 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.77e-04 | 68 | 172 | 6 | MM14921 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 1.89e-04 | 44 | 172 | 5 | M13720 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.92e-04 | 130 | 172 | 8 | MM14627 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.94e-04 | 98 | 172 | 7 | MM15352 | |
| Pubmed | 1.18e-17 | 9 | 206 | 8 | 21167302 | ||
| Pubmed | 9.44e-14 | 19 | 206 | 8 | 15698476 | ||
| Pubmed | 9.44e-14 | 19 | 206 | 8 | 15691386 | ||
| Pubmed | 3.94e-13 | 22 | 206 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.11e-12 | 8 | 206 | 6 | 16148047 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 3.60e-11 | 12 | 206 | 6 | 15331610 | |
| Pubmed | 3.65e-11 | 22 | 206 | 7 | 15103018 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 3.65e-11 | 22 | 206 | 7 | 23826228 | |
| Pubmed | 4.15e-11 | 6 | 206 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 4.15e-11 | 6 | 206 | 5 | 7651436 | |
| Pubmed | 4.15e-11 | 6 | 206 | 5 | 16327313 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 6.65e-11 | 13 | 206 | 6 | 10908577 | |
| Pubmed | 1.16e-10 | 14 | 206 | 6 | 12486001 | ||
| Pubmed | 1.44e-10 | 7 | 206 | 5 | 11146551 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYO1A RPN1 RPS17 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FLNB KRT6A KRT6B TUBA1C CAPZA1 MYH14 | 2.31e-10 | 288 | 206 | 15 | 31501420 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 8.58e-10 | 9 | 206 | 5 | 11953448 | |
| Pubmed | 1.20e-09 | 4 | 206 | 4 | 18400243 | ||
| Pubmed | DLGAP1 RPN1 TTC21A RPS17 TUBA4A ITPR2 MAGI2 TUBA1A SRGAP3 KCNQ3 PITPNM2 KRT2 FLNB KRT6A KRT6B BIN1 SEPTIN4 MAP4K3 TUBA1C CAPZA1 APC GRIA1 ELP3 TRIM3 MADD LRPPRC SF3B3 HNRNPUL2 MYH14 | 7.99e-09 | 1431 | 206 | 29 | 37142655 | |
| Pubmed | 4.06e-08 | 17 | 206 | 5 | 17360745 | ||
| Pubmed | 4.13e-08 | 7 | 206 | 4 | 36681692 | ||
| Pubmed | CASP14 RPN1 RPS17 TUBA4A NEDD4 TUBA1B KRT6C TUBA1A KRT2 FLNB KRT6A KRT6B PLOD3 PRDX4 TUBA1C CAPZA1 LRPPRC SF3B3 HNRNPUL2 MYH14 | 7.89e-08 | 803 | 206 | 20 | 36517590 | |
| Pubmed | 9.51e-08 | 94 | 206 | 8 | 36584595 | ||
| Pubmed | PRPF31 RPN1 RPS17 TUBA3E TUBA8 EFHB TUBA4A TUBA1B KRT6C TUBA1A FGFR3 DDX4 KRT2 KRT6A KRT6B PRDX4 TUBA1C CAPZA1 LRPPRC SF3B3 HNRNPUL2 MYH14 MRPS23 SPATA13 | 1.07e-07 | 1153 | 206 | 24 | 29845934 | |
| Pubmed | RPN1 PTGFRN GGH TUBA1B PCYOX1L NEU1 PTPRJ TUBA1A GNS PLOD3 TUBA1C CAPZA1 ATF6 LRPPRC SF3B3 EGFR LNPEP | 1.75e-07 | 613 | 206 | 17 | 22268729 | |
| Pubmed | CPNE8 CASP14 RPN1 RPS17 TUBA3E TUBA4A TUBA3C GGH TUBA1A KRT2 FLNB KRT6B TUBA1C CAPZA1 LRPPRC SF3B3 HNRNPUL2 MYH14 TRIM32 GIGYF2 | 1.75e-07 | 844 | 206 | 20 | 25963833 | |
| Pubmed | PRPF31 RPN1 RPS17 TUBA1B KRT6C KRT2 KRT6A KRT6B TUBA1C CAPZA1 LRPPRC HNRNPUL2 MRPS23 | 1.75e-07 | 346 | 206 | 13 | 25324306 | |
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 11163133 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 11121746 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 29357356 | ||
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 7543104 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.05e-07 | 3 | 206 | 3 | 9722999 | |
| Pubmed | PRPF31 RPN1 RPS17 TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A TUBA3D PRDX4 TUBA1C | 2.14e-07 | 239 | 206 | 11 | 23246001 | |
| Pubmed | 2.36e-07 | 191 | 206 | 10 | 33762435 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAF8 TTC21A ASH1L TMEFF2 JAK2 PCYOX1L PTPRJ KCNJ3 SEMA6A NQO2 KDM6A DOCK1 PITPNM2 FLNB RASA1 ABHD2 CAPZA1 ERGIC1 ANKRD44 ATF6 LRPPRC EGFR MYH14 SBF2 PRKCI IFT122 METTL15 | 2.56e-07 | 1489 | 206 | 27 | 28611215 |
| Pubmed | CASP14 RPN1 RPS17 TUBA4A TUBA1B KRT6C TUBA1A KRT2 FLNB KRT6A KRT6B PLOD3 TUBA1C CAPZA1 MYH14 | 2.61e-07 | 488 | 206 | 15 | 31324722 | |
| Pubmed | 3.14e-07 | 197 | 206 | 10 | 23686814 | ||
| Pubmed | 3.26e-07 | 75 | 206 | 7 | 31527668 | ||
| Pubmed | RPN1 TUBA3E TUBA8 TUBA1B KRT2 KRT6A LRPPRC SF3B3 MYH14 GIGYF2 | 3.96e-07 | 202 | 206 | 10 | 24639526 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | RPN1 RPS17 TUBA4A TUBA1B TUBA1A KRT2 FLNB KRT6A KRT6B FOLR1 PRDX4 CAPZA1 LRPPRC EGFR MYH14 MRPS23 | 4.37e-07 | 580 | 206 | 16 | 35676659 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPF31 CPNE8 RPN1 RPS17 TUBA4A NSD3 ITPR2 TUBA1B PUM3 KRT2 FLNB KRT6A KRT6B PLOD3 TUBA1C CAPZA1 SLU7 FAM83B LRPPRC SF3B3 EGFR HNRNPUL2 MRPS23 SPEN | 5.08e-07 | 1257 | 206 | 24 | 36526897 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 SETD1A CASP14 RPN1 RPS17 TUBA4A ATG4B ASPM PUM3 TAF2 KRT2 FLNB KRT6B MAP4K3 CAPZA1 SLU7 ELP3 LRPPRC SF3B3 HNRNPUL2 MYH14 TRIM32 MAP4K5 CHTF18 MRPS23 | 5.27e-07 | 1353 | 206 | 25 | 29467282 |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 33597177 | ||
| Pubmed | EphB2 receptor forward signaling controls cortical growth cone collapse via Nck and Pak. | 8.16e-07 | 4 | 206 | 3 | 23147113 | |
| Pubmed | Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma. | 8.16e-07 | 4 | 206 | 3 | 28759045 | |
| Pubmed | CPNE8 DCAF8 RPN1 ITPR2 PMPCA ASPM SEMA6A IFT80 USP48 PLOD3 PRDX4 TUBA1C KIF16B SLU7 TRAPPC8 FAM83B ATF6 LRPPRC SF3B3 EGFR LNPEP MAP4K5 MRPS23 PRKCI IFT122 PACSIN2 | 8.63e-07 | 1487 | 206 | 26 | 33957083 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CPNE8 RPN1 TUBA8 TUBA1B SEPTIN3 TUBA1A SRGAP3 KDM6A DDX4 BIN1 SEPTIN4 CAPZA1 TRIM3 ATL1 MTOR PACSIN2 | 1.07e-06 | 621 | 206 | 16 | 22794259 |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | ATP6V1B1 DCAF8 HAUS3 NSD3 GABPB2 CLK1 SRGAP3 KRT6A KRT6B SLU7 TNFAIP1 CDC23 | 1.08e-06 | 342 | 206 | 12 | 23455924 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PRPF31 DCAF8 RPS17 HAUS3 TUBA4A TUBA3C TUBA1B TUBA1A TUBA1C APC LRPPRC HNRNPUL2 TRIM32 MRPS23 GIGYF2 CDC23 | 1.55e-06 | 639 | 206 | 16 | 23443559 |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 2.03e-06 | 98 | 206 | 7 | 21942715 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 20301457 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PRPF31 RIPK1 ITPR2 JAK2 MLKL TUBA1B CLK1 FDXR SYK FGFR3 NQO2 PLOD3 MAP4K3 PRDX4 EGFR MAP4K5 PRKCI IPMK CDC23 | 2.34e-06 | 910 | 206 | 19 | 36736316 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRPF31 CASP14 MYO1A RPN1 ATG2A N4BP3 ATG4B PMPCA TUBA1A USP48 FLNB CNOT10 CAPZA1 APC FEM1B LRPPRC SPRYD3 GIGYF2 PRKCI TNFAIP1 | 2.59e-06 | 1005 | 206 | 20 | 19615732 |
| Pubmed | DLGAP1 DCAF8 PEG3 ASH1L DSCAML1 MAGI2 TUBA1B SEPTIN3 ZNF660 CLK1 GPSM2 KDM6A SESTD1 FLNB BIN1 APC MADD ATF6 RNF123 MYH14 TRIM32 IFT122 ZNF583 | 2.64e-06 | 1285 | 206 | 23 | 35914814 | |
| Pubmed | 3.02e-06 | 104 | 206 | 7 | 36055981 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 CPNE8 CASP14 TUBA4A ITPR2 TUBA1B KRT6C PUM3 FLNB KRT6A TUBA1C CAPZA1 FAM83B LRPPRC SF3B3 HNRNPUL2 MYH14 GIGYF2 SPEN CDC23 | 3.43e-06 | 1024 | 206 | 20 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.62e-06 | 202 | 206 | 9 | 33005030 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | PRPF31 CASP14 RPN1 RPS17 TUBA1B KRT6C TUBA1A PUM3 KRT2 KRT6A KRT6B SLU7 SF3B3 HNRNPUL2 SPEN | 3.73e-06 | 605 | 206 | 15 | 28977666 |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 18613978 | ||
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 12090300 | ||
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 10840040 | ||
| Pubmed | Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide. | 4.04e-06 | 6 | 206 | 3 | 28461567 | |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 15916950 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 4.17e-06 | 71 | 206 | 6 | 28319113 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PRPF31 NCOA3 DCAF8 RIPK1 RPS17 HAUS3 ATG2A N4BP3 TUBA4A TUBA1B PITPNM2 RBM33 SLU7 MADD MTOR SBF2 GIGYF2 PRKCI TNFAIP1 CDC23 | 4.20e-06 | 1038 | 206 | 20 | 26673895 |
| Pubmed | TUBA8 TUBA1B KRT6C TUBA1A KRT2 KRT6A KRT6B TUBA1C MYH14 MAP4K5 | 4.73e-06 | 266 | 206 | 10 | 19380743 | |
| Pubmed | DLGAP1 KCNH7 JAK2 GNS DOCK1 FLNB BIN1 MAP4K3 MAP4K5 KIF13A SPEN | 4.84e-06 | 329 | 206 | 11 | 17474147 | |
| Pubmed | NCOA3 DLGAP1 NEDD4 MAGI2 SEPTIN3 SRGAP3 SESTD1 BIN1 ZNF618 APC GRIA1 TRIM3 LRPPRC HNRNPUL2 MTOR GIGYF2 DGKI PRKCI SPATA13 | 5.28e-06 | 963 | 206 | 19 | 28671696 | |
| Pubmed | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C SF3B3 | 5.36e-06 | 212 | 206 | 9 | 23463506 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 6.24e-06 | 116 | 206 | 7 | 22810585 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 6.72e-06 | 218 | 206 | 9 | 35831895 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | COQ3 PTGFRN NEDD4 FDXR BIN1 MAP4K3 APC TRAPPC8 ELP3 MADD FEM1B ERGIC1 EGFR HNRNPUL2 KIF13A PACSIN2 | 6.90e-06 | 719 | 206 | 16 | 35337019 |
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 19720911 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PRPF31 RPN1 RPS17 NSD3 GGH TUBA1A CLK1 GNS KRT2 KRT6A ZNF618 PRDX4 APC SIM1 LRPPRC SF3B3 HNRNPUL2 TRIM32 MRPS23 SPEN | 7.72e-06 | 1082 | 206 | 20 | 38697112 |
| Pubmed | ATP6V1B1 PRSS8 AKR1A1 TUBA4A NEU1 TUBA1A KRT2 KRT6A KRT6B PLOD3 FOLR1 PRDX4 | 8.21e-06 | 417 | 206 | 12 | 19199708 | |
| Pubmed | PEG3 TUBA4A TUBA1B TUBA1A KRT6A KRT6B TUBA1C TEX15 EGFR CHTF18 | 8.39e-06 | 284 | 206 | 10 | 29459677 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | RIPK1 RPS17 TUBA4A TUBA1B MPP1 KRT2 KRT6A TUBA1C CAPZA1 APC MYH14 | 9.40e-06 | 353 | 206 | 11 | 27545878 |
| Pubmed | 1.04e-05 | 83 | 206 | 6 | 11114734 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | EPHB3 DSCAML1 MAGI2 PUM3 SEMA6A FGFR3 CNOT10 DLL1 S1PR1 EGFR MTOR | 1.07e-05 | 358 | 206 | 11 | 32460013 |
| Pubmed | 1.10e-05 | 176 | 206 | 8 | 27229929 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.11e-05 | 84 | 206 | 6 | 29563501 | |
| Pubmed | 1.12e-05 | 8 | 206 | 3 | 18485343 | ||
| Pubmed | 1.12e-05 | 8 | 206 | 3 | 7657660 | ||
| Pubmed | 1.16e-05 | 24 | 206 | 4 | 36718792 | ||
| Pubmed | RPS17 TUBA1B TUBA1A POC1B FGFR3 SESTD1 AKT3 BIN1 CAPZA1 SF3B3 EGFR | 1.22e-05 | 363 | 206 | 11 | 25036637 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPF31 RPN1 RPS17 TUBA4A MLKL TUBA1B KRT6C TUBA1A KRT2 FLNB KRT6A KRT6B PLOD3 PRDX4 TUBA1C CAPZA1 ELP3 LRPPRC SF3B3 EGFR CHTF18 MRPS23 GIGYF2 | 1.26e-05 | 1415 | 206 | 23 | 28515276 |
| Pubmed | PRPF31 KCNH7 RPN1 RPS17 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PLOD3 CAPZA1 SF3B3 | 1.34e-05 | 513 | 206 | 13 | 25798074 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPS17 TUBA8 TUBA4A TUBA1B TUBA1A KRT2 CNOT10 TUBA1C CAPZA1 SLU7 LRPPRC SF3B3 HNRNPUL2 MRPS23 GIGYF2 | 1.44e-05 | 678 | 206 | 15 | 30209976 |
| Pubmed | 1.68e-05 | 9 | 206 | 3 | 12817007 | ||
| Pubmed | 1.68e-05 | 9 | 206 | 3 | 19103752 | ||
| Pubmed | MYO1A RPN1 ASH1L RPS17 COQ3 KRT6C PMPCA ASPM OTUD3 KRT2 FLNB KRT6A KRT6B PRDX4 CAPZA1 GRIA1 LRPPRC SF3B3 MYH14 TNN IFT122 SPEN SPATA13 | 1.70e-05 | 1442 | 206 | 23 | 35575683 | |
| Pubmed | 1.70e-05 | 187 | 206 | 8 | 26460568 | ||
| Pubmed | 1.73e-05 | 54 | 206 | 5 | 35474131 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPN1 TTC21A RPS17 STING1 COQ3 NEDD4 GGH MAGI2 TUBA1B FIBIN FDXR NQO2 FLNB PLOD3 RBM33 PRDX4 KIF16B ERGIC1 LRPPRC SF3B3 EGFR LNPEP MRPS23 | 1.87e-05 | 1451 | 206 | 23 | 30550785 |
| Pubmed | 1.94e-05 | 249 | 206 | 9 | 30097533 | ||
| Pubmed | 2.19e-05 | 28 | 206 | 4 | 28410990 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 2.25e-05 | 95 | 206 | 6 | 27129302 | |
| Pubmed | 2.26e-05 | 57 | 206 | 5 | 18022353 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ATP6V1B1 CPNE8 PRSS8 AKR1A1 CFB NEDD4 GGH FREM2 NEU1 KRT6C PTPRJ NQO2 GNS TRHDE KRT2 FLNB KRT6A FOLR1 CAPZA1 | 2.29e-05 | 1070 | 206 | 19 | 23533145 |
| Pubmed | A model for obesity and gigantism due to disruption of the Ankrd26 gene. | 2.38e-05 | 10 | 206 | 3 | 18162531 | |
| Pubmed | 2.38e-05 | 10 | 206 | 3 | 29786074 | ||
| Interaction | TCP11L2 interactions | 1.49e-11 | 21 | 200 | 8 | int:TCP11L2 | |
| Interaction | D2HGDH interactions | RIPK1 HAUS3 TUBA1A TUBA1C MADD RNF123 TRIM32 MAP4K5 CHTF18 GIGYF2 IFT122 CDC23 | 2.53e-08 | 146 | 200 | 12 | int:D2HGDH |
| Interaction | GRM7 interactions | 9.51e-07 | 19 | 200 | 5 | int:GRM7 | |
| Interaction | ALDH3B1 interactions | 1.65e-06 | 111 | 200 | 9 | int:ALDH3B1 | |
| Interaction | SHC1 interactions | STING1 TUBA8 JAK2 TUBA1B TUBA1A SYK KRT2 KRT6A RASA1 MAP4K3 TUBA1C EGFR CD22 MYH14 MAP4K5 | 3.55e-06 | 362 | 200 | 15 | int:SHC1 |
| Interaction | FOXRED2 interactions | 5.14e-06 | 96 | 200 | 8 | int:FOXRED2 | |
| Interaction | HDAC6 interactions | SETD1A RPN1 RPS17 STING1 COQ3 TUBA8 TUBA4A JAK2 TUBA1B TUBA1A SYK RNF145 KRT2 FLNB KRT6A KRT6B BIN1 FOLR1 PRDX4 TUBA1C CAPZA1 LRPPRC EGFR MYH14 MRPS23 | 5.85e-06 | 929 | 200 | 25 | int:HDAC6 |
| Interaction | HYAL1 interactions | 8.96e-06 | 29 | 200 | 5 | int:HYAL1 | |
| Interaction | KRT28 interactions | 1.07e-05 | 30 | 200 | 5 | int:KRT28 | |
| Interaction | CD81 interactions | MC4R TUBA3E TUBA8 PTGFRN TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C SF3B3 EGFR CD53 | 1.11e-05 | 303 | 200 | 13 | int:CD81 |
| Interaction | RPS6KB2 interactions | RPN1 RPS17 TUBA1B SYK NQO2 KRT2 KRT6A AKT3 TUBA1C CAPZA1 LRPPRC MTOR | 1.23e-05 | 261 | 200 | 12 | int:RPS6KB2 |
| Interaction | EFNA3 interactions | 1.23e-05 | 108 | 200 | 8 | int:EFNA3 | |
| Interaction | GABARAPL2 interactions | NEDD4 ATG4B SEPTIN3 VDR KIF16B LRPPRC RNF123 EGFR TRIM32 PRKCI | 1.44e-05 | 182 | 200 | 10 | int:GABARAPL2 |
| Interaction | SIAH1 interactions | PRPF31 PEG3 TUBA8 TUBA4A TUBA3C NEDD4 TUBA1B TUBA1A SEPTIN4 APC CDC23 | 1.48e-05 | 223 | 200 | 11 | int:SIAH1 |
| Interaction | BAG2 interactions | SETD1A DCAF8 RIPK1 HAUS3 STING1 HPSE TUBA1A POC1B TAF2 KDM6A RBM33 TUBA1C KIF16B SLU7 EGFR TRIM32 PRKCI IFT122 SPEN | 1.49e-05 | 622 | 200 | 19 | int:BAG2 |
| Interaction | CRK interactions | EPHB3 GABPB2 TUBA1A KCNJ3 DOCK1 KRT2 KRT6A KRT6B TUBA1C CAPZA1 EGFR MAP4K5 CHTF18 SPEN | 2.09e-05 | 370 | 200 | 14 | int:CRK |
| Interaction | PPARD interactions | 2.21e-05 | 117 | 200 | 8 | int:PPARD | |
| Interaction | PTK2B interactions | 2.50e-05 | 119 | 200 | 8 | int:PTK2B | |
| Interaction | FES interactions | 3.12e-05 | 61 | 200 | 6 | int:FES | |
| Interaction | TFCP2 interactions | MYO1A RPN1 RPS17 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A FLNB KRT6A KRT6B TUBA1C CAPZA1 MYH14 | 3.20e-05 | 436 | 200 | 15 | int:TFCP2 |
| Interaction | PHTF1 interactions | 4.03e-05 | 20 | 200 | 4 | int:PHTF1 | |
| Interaction | MEPCE interactions | PRPF31 RPN1 RPS17 TUBA3E TUBA8 EFHB TUBA4A TUBA1B KRT6C TUBA1A TAF2 DDX4 DOCK1 KRT2 KRT6A KRT6B TUBA1C LRPPRC SF3B3 EGFR HNRNPUL2 MRPS23 | 4.65e-05 | 859 | 200 | 22 | int:MEPCE |
| Interaction | DDX39B interactions | PRPF31 CASP14 RPN1 TUBA4A NEDD4 KRT6C TUBA1A USP48 KRT2 KRT6A KRT6B RBM33 CAPZA1 SLU7 SF3B3 HNRNPUL2 MYH14 | 5.73e-05 | 570 | 200 | 17 | int:DDX39B |
| Interaction | CBL interactions | RIPK1 STING1 TUBA4A NEDD4 JAK2 KRT6C TUBA1A SYK KRT2 KRT6A KRT6B PRDX4 TUBA1C CAPZA1 EGFR EPHB1 | 6.04e-05 | 516 | 200 | 16 | int:CBL |
| Interaction | ZUP1 interactions | 6.22e-05 | 174 | 200 | 9 | int:ZUP1 | |
| Interaction | LGR4 interactions | RPN1 TUBA3E TUBA8 NEDD4 TUBA1B KRT2 KRT6A LRPPRC SF3B3 MYH14 GIGYF2 | 6.48e-05 | 262 | 200 | 11 | int:LGR4 |
| Interaction | MYH9 interactions | NCOA3 STING1 TUBA4A ITPR2 TUBA1B OTUD3 USP48 GNS FLNB FOLR1 CAPZA1 LRPPRC RNF123 EGFR HNRNPUL2 MYH14 GIGYF2 PRKCI TNFAIP1 MYBPC3 | 6.50e-05 | 754 | 200 | 20 | int:MYH9 |
| Interaction | BAGE2 interactions | 6.85e-05 | 70 | 200 | 6 | int:BAGE2 | |
| Interaction | ECT2 interactions | MYO1A RPN1 RPS17 N4BP3 ITPR2 TUBA1A ASPM GPSM2 TAF2 FLNB FOLR1 PRDX4 CAPZA1 MADD FAM83B LRPPRC RNF123 SF3B3 EGFR MYH14 TRIM32 GIGYF2 | 7.46e-05 | 887 | 200 | 22 | int:ECT2 |
| Interaction | EFNA1 interactions | 7.57e-05 | 103 | 200 | 7 | int:EFNA1 | |
| Interaction | PTK2 interactions | DLGAP1 DCAF8 RIPK1 STING1 JAK2 TUBA1A SYK DOCK1 BIN1 APC EGFR PRKCI | 7.70e-05 | 315 | 200 | 12 | int:PTK2 |
| Interaction | KCTD9 interactions | TUBA1B TUBA1A KRT2 FLNB PLOD3 TUBA1C LRPPRC SF3B3 EGFR TRIM32 | 8.74e-05 | 225 | 200 | 10 | int:KCTD9 |
| Interaction | YAP1 interactions | SETD1A MYO1A RPN1 RPS17 TUBA3E TUBA8 TUBA4A TUBA3C NSD3 NEDD4 TUBA1B TUBA1A TAF2 KDM6A FLNB KRT6A KRT6B TUBA1C CAPZA1 SF3B3 EGFR MYH14 GIGYF2 SPEN CDC23 | 8.93e-05 | 1095 | 200 | 25 | int:YAP1 |
| Interaction | SSR2 interactions | 9.02e-05 | 46 | 200 | 5 | int:SSR2 | |
| Interaction | GZMH interactions | 9.37e-05 | 74 | 200 | 6 | int:GZMH | |
| Interaction | ERRFI1 interactions | 9.63e-05 | 107 | 200 | 7 | int:ERRFI1 | |
| Interaction | VAV1 interactions | TUBA3E TUBA4A TUBA3C JAK2 TUBA1B TUBA1A SYK PRDX4 ARHGDIB EGFR | 9.75e-05 | 228 | 200 | 10 | int:VAV1 |
| Interaction | PACSIN2 interactions | 9.96e-05 | 185 | 200 | 9 | int:PACSIN2 | |
| Interaction | FBXO6 interactions | RPN1 PTGFRN GGH TUBA1B PCYOX1L NEU1 PTPRJ TUBA1A FGFR3 GNS TRHDE PLOD3 TUBA1C CAPZA1 ATF6 LRPPRC SF3B3 EGFR LNPEP | 1.01e-04 | 717 | 200 | 19 | int:FBXO6 |
| Interaction | AP2M1 interactions | STING1 TUBA1B TUBA1A USP48 MPP1 KRT2 KRT6A KRT6B TUBA1C APC EGFR CD22 DGKI KIF13A | 1.06e-04 | 430 | 200 | 14 | int:AP2M1 |
| Interaction | KLK5 interactions | 1.08e-04 | 109 | 200 | 7 | int:KLK5 | |
| Interaction | DNAJC5 interactions | ATP6V1B1 CPNE8 SEMA6A USP48 KIF16B TRAPPC8 FAM83B EGFR SLC18A2 LNPEP MAP4K5 PRKCI PACSIN2 | 1.09e-04 | 378 | 200 | 13 | int:DNAJC5 |
| Interaction | DSCAML1 interactions | 1.10e-04 | 10 | 200 | 3 | int:DSCAML1 | |
| Interaction | BLNK interactions | 1.11e-04 | 48 | 200 | 5 | int:BLNK | |
| Interaction | SULT1C4 interactions | 1.15e-04 | 110 | 200 | 7 | int:SULT1C4 | |
| Interaction | WDR76 interactions | PRPF31 DCAF8 RPS17 STING1 TUBA1B FREM2 TUBA1A USP48 FLNB PLOD3 TUBA1C LRPPRC SF3B3 | 1.24e-04 | 383 | 200 | 13 | int:WDR76 |
| Interaction | PLEKHG7 interactions | 1.29e-04 | 150 | 200 | 8 | int:PLEKHG7 | |
| Interaction | MKRN2 interactions | EPHB3 DSCAML1 MAGI2 CLK1 SEMA6A FGFR3 CNOT10 APC DLL1 S1PR1 EGFR HNRNPUL2 MTOR | 1.31e-04 | 385 | 200 | 13 | int:MKRN2 |
| Interaction | DHFR interactions | 1.42e-04 | 152 | 200 | 8 | int:DHFR | |
| Interaction | PTEN interactions | NCOA3 RPS17 PTGFRN TUBA3C CFB NEDD4 MAGI2 TUBA1B SEPTIN3 TUBA1A OTUD3 KDM6A MPP1 FLNB BIN1 TUBA1C LRPPRC SF3B3 EGFR MTOR MRPS23 EPHB1 | 1.45e-04 | 929 | 200 | 22 | int:PTEN |
| Interaction | RAC1 interactions | NCOA3 DLGAP1 CPNE8 RPN1 TUBA4A NEDD4 TUBA1B PTPRJ TUBA1A SRGAP3 USP48 DOCK1 FLNB BIN1 FAM83B ARHGDIB LRPPRC EGFR MTOR LNPEP MAP4K5 PRKCI PACSIN2 CDC23 | 1.48e-04 | 1063 | 200 | 24 | int:RAC1 |
| Interaction | MAP1LC3A interactions | CHDH ATG2A TUBA4A NEDD4 TUBA1B ATG4B PRDX4 EGFR TRIM32 PRKCI | 1.54e-04 | 241 | 200 | 10 | int:MAP1LC3A |
| Interaction | LTA interactions | 1.60e-04 | 28 | 200 | 4 | int:LTA | |
| Interaction | BACE2 interactions | 1.66e-04 | 82 | 200 | 6 | int:BACE2 | |
| Interaction | NCK1 interactions | 1.70e-04 | 244 | 200 | 10 | int:NCK1 | |
| Interaction | TUBB4A interactions | PRSS8 TUBA3E TUBA4A TUBA1B ATG4B USP48 TUBA1C EGFR MTOR TNFAIP1 | 1.70e-04 | 244 | 200 | 10 | int:TUBB4A |
| Interaction | SH2B2 interactions | 1.95e-04 | 54 | 200 | 5 | int:SH2B2 | |
| Interaction | SAMD9L interactions | 1.98e-04 | 12 | 200 | 3 | int:SAMD9L | |
| Interaction | BANK1 interactions | 1.98e-04 | 12 | 200 | 3 | int:BANK1 | |
| Interaction | LRRC31 interactions | 2.16e-04 | 205 | 200 | 9 | int:LRRC31 | |
| Interaction | CRYL1 interactions | 2.32e-04 | 56 | 200 | 5 | int:CRYL1 | |
| Interaction | FGD5 interactions | 2.32e-04 | 207 | 200 | 9 | int:FGD5 | |
| Interaction | SEPTIN6 interactions | 2.44e-04 | 88 | 200 | 6 | int:SEPTIN6 | |
| Interaction | PRPF8 interactions | PRPF31 RPS17 TUBA4A NEDD4 TUBA1B KRT2 KRT6A KRT6B RBM33 PRDX4 TUBA1C CAPZA1 SLU7 ASB15 RNF123 SF3B3 EGFR GIGYF2 SPEN | 2.77e-04 | 776 | 200 | 19 | int:PRPF8 |
| Interaction | KCTD13 interactions | DLGAP1 RPN1 TTC21A RPS17 ITPR2 MAGI2 TUBA1A SRGAP3 KCNQ3 PITPNM2 KRT2 FLNB KRT6A BIN1 SEPTIN4 MAP4K3 TUBA1C CAPZA1 APC GRIA1 ELP3 TRIM3 MADD LRPPRC SF3B3 HNRNPUL2 MYH14 TNFAIP1 | 2.86e-04 | 1394 | 200 | 28 | int:KCTD13 |
| Interaction | DOK1 interactions | 2.97e-04 | 59 | 200 | 5 | int:DOK1 | |
| Interaction | AASDH interactions | 3.23e-04 | 14 | 200 | 3 | int:AASDH | |
| Interaction | KRT38 interactions | 3.29e-04 | 172 | 200 | 8 | int:KRT38 | |
| Interaction | CUL4A interactions | KCNH7 CASP14 DCAF8 RIPK1 STING1 TUBA4A JAK2 TUBA1B POC1B KRT2 SEPTIN4 TUBA1C TRAPPC8 FEM1B LRPPRC SF3B3 EGFR MTOR CDC23 MYBPC3 | 3.39e-04 | 854 | 200 | 20 | int:CUL4A |
| Interaction | IQCB1 interactions | TUBA4A TUBA1B KRT6C TUBA1A KRT2 SESTD1 FLNB KRT6A KRT6B TUBA1C TRIM32 IFT122 | 3.42e-04 | 370 | 200 | 12 | int:IQCB1 |
| Interaction | SLC35G1 interactions | 3.46e-04 | 34 | 200 | 4 | int:SLC35G1 | |
| Interaction | COL17A1 interactions | 3.46e-04 | 34 | 200 | 4 | int:COL17A1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | MYO1A TUBA1B KRT6C TUBA1A ASB8 VDR KRT2 KRT6A KRT6B TUBA1C SPRYD3 | 3.88e-06 | 423 | 206 | 11 | chr12q13 |
| Cytoband | 12q13.13 | 1.33e-05 | 67 | 206 | 5 | 12q13.13 | |
| Cytoband | 1q22-q23 | 2.46e-05 | 13 | 206 | 3 | 1q22-q23 | |
| Cytoband | 17q22-q23 | 2.97e-04 | 6 | 206 | 2 | 17q22-q23 | |
| Cytoband | 11p11.2 | 5.48e-04 | 83 | 206 | 4 | 11p11.2 | |
| Cytoband | 12q13.12 | 6.69e-04 | 38 | 206 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 2.30e-11 | 26 | 148 | 8 | 778 | |
| GeneFamily | Keratins, type II | 6.53e-05 | 27 | 148 | 4 | 609 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.68e-04 | 115 | 148 | 6 | 769 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 6.55e-04 | 5 | 148 | 2 | 655 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 9.59e-04 | 24 | 148 | 3 | 615 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.08e-03 | 25 | 148 | 3 | 504 | |
| GeneFamily | Myosins, class I | 1.80e-03 | 8 | 148 | 2 | 1097 | |
| GeneFamily | Fibronectin type III domain containing | 2.05e-03 | 160 | 148 | 6 | 555 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.67e-03 | 34 | 148 | 3 | 487 | |
| GeneFamily | Ankyrin repeat domain containing | 3.82e-03 | 242 | 148 | 7 | 403 | |
| GeneFamily | Potassium voltage-gated channels | 4.25e-03 | 40 | 148 | 3 | 274 | |
| GeneFamily | Septins | 4.89e-03 | 13 | 148 | 2 | 732 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | NCOA3 DENND2D JAK2 GABPB2 RNF145 DDX4 BIN1 ABHD2 ANKRD44 AP4S1 IFT122 | 5.48e-07 | 200 | 205 | 11 | M9492 |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 5.26e-06 | 161 | 205 | 9 | M11857 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | HAUS3 ITPR2 GGH JAK2 CLK1 SYK KDM6A GNS MPP1 FLNB AKT3 BIN1 RASA1 ABHD2 PRDX4 CAPZA1 APC TRAPPC8 ELL3 FEM1B LRPPRC SLC18A2 MAP4K5 PRKCI EPHB1 | 1.03e-05 | 1215 | 205 | 25 | M41122 |
| Coexpression | RELA_DN.V1_UP | 2.37e-05 | 149 | 205 | 8 | M2696 | |
| Coexpression | GSE7831_1H_VS_4H_CPG_STIM_PDC_DN | 2.87e-05 | 199 | 205 | 9 | M6961 | |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_UP | 2.98e-05 | 200 | 205 | 9 | M3224 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP | 2.98e-05 | 200 | 205 | 9 | M7475 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 171 | 206 | 8 | 656a9f407461dbf5c9c0bd234399e1fef6abce2a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 178 | 206 | 8 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 178 | 206 | 8 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-06 | 185 | 206 | 8 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 186 | 206 | 8 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 186 | 206 | 8 | f8ed078684ce6d914fd9cb1f0ef4aba36db39b3f | |
| ToppCell | facs-Heart-LA-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 186 | 206 | 8 | 1d08e60d239153c9e5ea42135d702d494d8b42b1 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.67e-06 | 187 | 206 | 8 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 187 | 206 | 8 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 187 | 206 | 8 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.67e-06 | 187 | 206 | 8 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 190 | 206 | 8 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 190 | 206 | 8 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-06 | 191 | 206 | 8 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-06 | 192 | 206 | 8 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 192 | 206 | 8 | 9b8191e66626919cad2c63349c8ef61e9792fcf5 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-06 | 193 | 206 | 8 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-06 | 194 | 206 | 8 | 4a4cc61193344bb151439f63d0584abddde47cf0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-06 | 194 | 206 | 8 | 9116451614431e3cf9bd7d4d626bf4bd23420e36 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-06 | 195 | 206 | 8 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.22e-06 | 199 | 206 | 8 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.38e-06 | 200 | 206 | 8 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.38e-06 | 200 | 206 | 8 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 167 | 206 | 7 | d72b08b3cbc34b30a11dcf512e472b64d1606ec1 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 167 | 206 | 7 | 22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 168 | 206 | 7 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 169 | 206 | 7 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 170 | 206 | 7 | 6086d658a52a1961a1e293cbc3703ae8d309cd11 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 170 | 206 | 7 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 173 | 206 | 7 | 71c90c57225e452c73bf7bea46b454c472bf5f76 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 173 | 206 | 7 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | Tuft-tuft-4|World / Class top | 1.69e-05 | 174 | 206 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 176 | 206 | 7 | 077f3fe5e3482ea3f639d789bd3d584161b36c02 | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 176 | 206 | 7 | fc2ba468677b19b55130c1f06737f40300cd9d2e | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-05 | 177 | 206 | 7 | 325c10674b18727ddd50bf088a9c6f4ef29aa809 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 177 | 206 | 7 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 178 | 206 | 7 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 178 | 206 | 7 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 206 | 7 | de3245e1ee269e422de0308d0dd3623e4e9eb182 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 179 | 206 | 7 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 206 | 7 | c41c11171dfb40e5ddea6bf97d9373eb03a2321b | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 180 | 206 | 7 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 182 | 206 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-05 | 182 | 206 | 7 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-05 | 182 | 206 | 7 | 8737142aa4c8301fb5b0ad5bef596471ac316743 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-Zbtb32+_B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-05 | 182 | 206 | 7 | 632014a6e042d09302f4631ca3a1da36af7a7c98 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 183 | 206 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 183 | 206 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 185 | 206 | 7 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 186 | 206 | 7 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 186 | 206 | 7 | e3807508a5da6c8c7081129a5f785ccecaf5ebba | |
| ToppCell | Tuft|World / Class top | 2.60e-05 | 186 | 206 | 7 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 186 | 206 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.60e-05 | 186 | 206 | 7 | 35f32fc2761435356c8f54b5bb2f026b8c070efe | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 187 | 206 | 7 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | (1)_B_CD27pos|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.69e-05 | 187 | 206 | 7 | bb189942123eb03dd6505f1af8771dd7285bb8b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 187 | 206 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 187 | 206 | 7 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | Tuft-tuft-2|World / Class top | 2.69e-05 | 187 | 206 | 7 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-05 | 189 | 206 | 7 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 190 | 206 | 7 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 190 | 206 | 7 | 95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 192 | 206 | 7 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 192 | 206 | 7 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.18e-05 | 192 | 206 | 7 | ac3d87aa301d30515c369bd7fc16f33b82173a85 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 192 | 206 | 7 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-05 | 193 | 206 | 7 | 8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.29e-05 | 193 | 206 | 7 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-05 | 194 | 206 | 7 | ea5b7727ffef6cb454c501979a51bc1d4108d0e4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | d77423d0ec64b397c6d1eec181c5fc0acaa92d63 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | f5bf4797972185afa76638293166abd536e5472f | |
| ToppCell | PBMC-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 3.51e-05 | 195 | 206 | 7 | c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-05 | 195 | 206 | 7 | e3df097e894b96b7d23db35bd527a8de6a055e52 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 195 | 206 | 7 | 804b7c44aaaf8ba77e36f377955df261e92f5ff9 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.63e-05 | 196 | 206 | 7 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.63e-05 | 196 | 206 | 7 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 196 | 206 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 196 | 206 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 196 | 206 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-05 | 197 | 206 | 7 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-05 | 197 | 206 | 7 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.75e-05 | 197 | 206 | 7 | c395abd57d276e7cb5454cad3afa962fd42059f3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-05 | 197 | 206 | 7 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-05 | 198 | 206 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.87e-05 | 198 | 206 | 7 | 8a21c183283fbc871aa729f8c42924b63018c345 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.87e-05 | 198 | 206 | 7 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 198 | 206 | 7 | 0dac00a64fe08ec6669af3ddd4b82413b673233d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-05 | 198 | 206 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.94e-05 | 135 | 206 | 6 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 206 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 5'-GW_trimst-2-LymphNode|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 199 | 206 | 7 | 4a9ca133125dc25a06e7b1cfea15ecffa449c20e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 206 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Sigmoid-T_cell-Tcm|T_cell / Region, Cell class and subclass | 4.00e-05 | 199 | 206 | 7 | acdf95f4d58df47690f4ae254245bc618f9ac07e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.00e-05 | 199 | 206 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.13e-05 | 200 | 206 | 7 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.13e-05 | 200 | 206 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.13e-05 | 200 | 206 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.13e-05 | 200 | 206 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.13e-05 | 200 | 206 | 7 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| Drug | Epothilone D | 4.12e-10 | 12 | 203 | 6 | DB01873 | |
| Drug | Epothilone B | 4.12e-10 | 12 | 203 | 6 | DB03010 | |
| Drug | NSC339663 | MYO1A TUBA3E TUBA8 TUBA4A KRT6C TUBA1A DOCK1 KRT6A KRT6B FOLR1 TUBA1C MYH14 MTOR EPHB1 | 5.98e-08 | 250 | 203 | 14 | CID000003892 |
| Drug | indibulin | 9.26e-08 | 26 | 203 | 6 | CID000002929 | |
| Drug | TK-B | 3.35e-07 | 51 | 203 | 7 | CID000009074 | |
| Drug | 2-demethylcolchicine | 3.48e-07 | 32 | 203 | 6 | CID000023757 | |
| Drug | dimethylarsinic acid | 5.03e-07 | 107 | 203 | 9 | CID000002513 | |
| Drug | AC1L8WWP | 6.47e-07 | 56 | 203 | 7 | CID000388944 | |
| Drug | DTAF | 8.61e-07 | 37 | 203 | 6 | CID000123934 | |
| Drug | bromocolchicine | 9.72e-07 | 21 | 203 | 5 | CID000161518 | |
| Drug | colchifoline | 9.72e-07 | 21 | 203 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 9.72e-07 | 21 | 203 | 5 | CID000164454 | |
| Drug | SRI-3072 | 9.72e-07 | 21 | 203 | 5 | CID000493469 | |
| Drug | diazoxide | KCNH7 TUBA3E TUBA8 TUBA4A TUBA1A KCNJ3 KCNQ3 GNS TUBA1C GRIA1 KCNQ4 PRKCI | 9.94e-07 | 227 | 203 | 12 | CID000003019 |
| Drug | 3,4,5-trimethoxyacetophenone | 1.25e-06 | 22 | 203 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 1.25e-06 | 22 | 203 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.25e-06 | 22 | 203 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 1.25e-06 | 22 | 203 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.25e-06 | 22 | 203 | 5 | CID000023759 | |
| Drug | NSC-339672 | 1.25e-06 | 22 | 203 | 5 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.58e-06 | 23 | 203 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 1.58e-06 | 23 | 203 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 1.58e-06 | 23 | 203 | 5 | CID000125548 | |
| Drug | NSC-373301 | 1.58e-06 | 23 | 203 | 5 | CID000341375 | |
| Drug | NSC355636 | 1.58e-06 | 23 | 203 | 5 | CID000100176 | |
| Drug | IKP104 | 1.58e-06 | 23 | 203 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.58e-06 | 23 | 203 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.58e-06 | 23 | 203 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.58e-06 | 23 | 203 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.58e-06 | 23 | 203 | 5 | CID000097865 | |
| Drug | amoebal | 1.62e-06 | 41 | 203 | 6 | CID000001985 | |
| Drug | rotigotine patch | 1.85e-06 | 93 | 203 | 8 | CID003619466 | |
| Drug | parbendazole | 1.99e-06 | 24 | 203 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 1.99e-06 | 24 | 203 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.99e-06 | 24 | 203 | 5 | CID000330401 | |
| Drug | NABV | 1.99e-06 | 24 | 203 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 1.99e-06 | 24 | 203 | 5 | CID000163705 | |
| Drug | moscatilin | 1.99e-06 | 24 | 203 | 5 | CID000176096 | |
| Drug | NSC-36768 | 1.99e-06 | 24 | 203 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.99e-06 | 24 | 203 | 5 | CID000014995 | |
| Drug | colchicide | 1.99e-06 | 24 | 203 | 5 | CID000120712 | |
| Drug | AC1MHEDK | 2.01e-06 | 94 | 203 | 8 | CID003002889 | |
| Drug | mpMap | 2.46e-06 | 25 | 203 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 2.46e-06 | 25 | 203 | 5 | CID000160263 | |
| Drug | allocolchicine | 2.46e-06 | 25 | 203 | 5 | CID000196989 | |
| Drug | 1069C85 | 2.46e-06 | 25 | 203 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 2.46e-06 | 25 | 203 | 5 | CID006438440 | |
| Drug | MDL 27048 | 2.46e-06 | 25 | 203 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 2.46e-06 | 25 | 203 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.46e-06 | 25 | 203 | 5 | CID000043264 | |
| Drug | CA1P | 2.46e-06 | 25 | 203 | 5 | CID006918545 | |
| Drug | peloruside A | 2.46e-06 | 25 | 203 | 5 | CID006918506 | |
| Drug | NSC142227 | 2.46e-06 | 25 | 203 | 5 | CID000073427 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 2.78e-06 | 4 | 203 | 3 | DB07574 | |
| Drug | NSC527981 | 3.03e-06 | 26 | 203 | 5 | CID000352796 | |
| Drug | NSC332029 | 3.03e-06 | 26 | 203 | 5 | CID000100073 | |
| Drug | pironetin | 3.03e-06 | 26 | 203 | 5 | CID006438891 | |
| Drug | isaxonine | 3.03e-06 | 26 | 203 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 3.69e-06 | 27 | 203 | 5 | CID000004862 | |
| Drug | dinitroanilines | 3.69e-06 | 27 | 203 | 5 | CID000136400 | |
| Drug | NSC292222 | 3.69e-06 | 27 | 203 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 3.69e-06 | 27 | 203 | 5 | CID000178028 | |
| Drug | NSC 370147 | 4.46e-06 | 28 | 203 | 5 | CID000182762 | |
| Drug | NSC72302 | 4.46e-06 | 28 | 203 | 5 | CID000118078 | |
| Drug | bp U | 5.35e-06 | 29 | 203 | 5 | CID000368697 | |
| Drug | oxibendazole | 5.35e-06 | 29 | 203 | 5 | CID000004622 | |
| Drug | Aids106696 | 5.35e-06 | 29 | 203 | 5 | CID006475933 | |
| Drug | ddGDP | 5.35e-06 | 29 | 203 | 5 | CID000134739 | |
| Drug | AC1NBBHE | 6.38e-06 | 30 | 203 | 5 | CID004490620 | |
| Drug | eleutherobin | 6.38e-06 | 30 | 203 | 5 | CID006918335 | |
| Drug | azatoxin | 6.38e-06 | 30 | 203 | 5 | CID000125383 | |
| Drug | NSC617668 | 6.38e-06 | 30 | 203 | 5 | CID000357989 | |
| Drug | citostal | 6.38e-06 | 30 | 203 | 5 | CID000018991 | |
| Drug | thiocolchicine | 6.38e-06 | 30 | 203 | 5 | CID000017648 | |
| Drug | vinflunine | 6.75e-06 | 52 | 203 | 6 | CID000157688 | |
| Drug | NSC609395 | 7.55e-06 | 31 | 203 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 7.55e-06 | 31 | 203 | 5 | CID000100524 | |
| Drug | AC7700 | 7.55e-06 | 31 | 203 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 7.55e-06 | 31 | 203 | 5 | CID000032851 | |
| Drug | tropone | 7.55e-06 | 31 | 203 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 7.55e-06 | 31 | 203 | 5 | CID000122777 | |
| Drug | NSC332598 | 7.55e-06 | 31 | 203 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 7.55e-06 | 31 | 203 | 5 | CID000023678 | |
| Drug | tropolone | 7.56e-06 | 53 | 203 | 6 | CID000010789 | |
| Drug | NSC91998 | 8.04e-06 | 81 | 203 | 7 | CID000005668 | |
| Drug | epo906 | 8.53e-06 | 114 | 203 | 8 | CID000388945 | |
| Drug | AC1L1G95 | 8.88e-06 | 32 | 203 | 5 | CID000003583 | |
| Drug | NSC153858 | 8.88e-06 | 32 | 203 | 5 | CID000547450 | |
| Drug | E2-3,4-Q | 8.88e-06 | 32 | 203 | 5 | CID000067402 | |
| Drug | mebendazole | 1.04e-05 | 33 | 203 | 5 | CID000004030 | |
| Drug | CA4P | 1.04e-05 | 33 | 203 | 5 | CID000370232 | |
| Drug | taltobulin | 1.04e-05 | 33 | 203 | 5 | CID006918637 | |
| Drug | cignolin | 1.05e-05 | 56 | 203 | 6 | CID000010187 | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.15e-05 | 197 | 203 | 10 | 2300_DN | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | SETD1A DCAF8 NSD3 ITPR2 JAK2 KCNJ3 RNASEH2B DMC1 HNRNPUL2 SPEN | 1.21e-05 | 198 | 203 | 10 | 889_DN |
| Drug | triethyllead | 1.21e-05 | 34 | 203 | 5 | CID006328106 | |
| Drug | NSC376450 | 1.21e-05 | 34 | 203 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.21e-05 | 34 | 203 | 5 | CID000161091 | |
| Drug | SC-791 | 1.37e-05 | 6 | 203 | 3 | CID010291510 | |
| Drug | discodermolide | 1.40e-05 | 35 | 203 | 5 | CID000643668 | |
| Disease | microlissencephaly (implicated_via_orthology) | 3.42e-18 | 8 | 197 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 3.42e-18 | 8 | 197 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 3.42e-18 | 8 | 197 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 6.82e-12 | 27 | 197 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Intellectual Disability | SETD1A PUS3 ASH1L TUBA1A SRGAP3 TAF2 RNASEH2B FOLR1 APC GRIA1 DLL1 ATL1 MTOR | 1.08e-05 | 447 | 197 | 13 | C3714756 |
| Disease | prostate cancer (is_implicated_in) | 1.42e-05 | 117 | 197 | 7 | DOID:10283 (is_implicated_in) | |
| Disease | long QT syndrome (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:2843 (implicated_via_orthology) | |
| Disease | Short rib-polydactyly syndrome, Beemer type | 4.43e-05 | 2 | 197 | 2 | C0432198 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 6.78e-05 | 33 | 197 | 4 | DOID:10003 (is_implicated_in) | |
| Disease | cervical cancer | 7.64e-05 | 34 | 197 | 4 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 8.58e-05 | 35 | 197 | 4 | C0007873 | |
| Disease | schizophrenia (implicated_via_orthology) | 9.34e-05 | 68 | 197 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | sphingomyelin measurement | 1.13e-04 | 278 | 197 | 9 | EFO_0010118 | |
| Disease | Benign neoplasm of bladder | 1.26e-04 | 15 | 197 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.26e-04 | 15 | 197 | 3 | C0154091 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.26e-04 | 15 | 197 | 3 | C0496930 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.32e-04 | 3 | 197 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | nervousness | 1.54e-04 | 16 | 197 | 3 | NCIT_C74532 | |
| Disease | Mesothelioma | 1.61e-04 | 41 | 197 | 4 | C0025500 | |
| Disease | Carcinoma, Transitional Cell | 1.61e-04 | 41 | 197 | 4 | C0007138 | |
| Disease | HbA1c measurement | ASH1L DENND2D OR4C3 PMPCA PTPRJ VDR MED30 TUBA1C ASB15 MADD RNF123 MAP4K5 SBF2 MYBPC3 | 1.92e-04 | 675 | 197 | 14 | EFO_0004541 |
| Disease | Carcinoma of bladder | 2.22e-04 | 18 | 197 | 3 | C0699885 | |
| Disease | Tourette syndrome, schizophrenia | 2.22e-04 | 18 | 197 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | breast cancer (is_marker_for) | 2.56e-04 | 185 | 197 | 7 | DOID:1612 (is_marker_for) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 2.64e-04 | 4 | 197 | 2 | C1706595 | |
| Disease | Pachyonychia congenita syndrome | 2.64e-04 | 4 | 197 | 2 | cv:C0265334 | |
| Disease | pachyonychia congenita (is_implicated_in) | 2.64e-04 | 4 | 197 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 2.64e-04 | 4 | 197 | 2 | C1721007 | |
| Disease | chronotype measurement | CPNE8 ZNF536 MAGI2 PMPCA SEMA6A USP48 DOCK1 RASA1 ZNF618 CAPZA1 KIF16B MADD FAM83B LRPPRC RNF123 METTL15 | 3.05e-04 | 882 | 197 | 16 | EFO_0008328 |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.53e-04 | 195 | 197 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 3.67e-04 | 140 | 197 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.81e-04 | 141 | 197 | 6 | C0005684 | |
| Disease | Pachyonychia Congenita | 4.38e-04 | 5 | 197 | 2 | C0265334 | |
| Disease | clonal hematopoiesis mutation measurement | 5.04e-04 | 55 | 197 | 4 | EFO_0020949 | |
| Disease | breast carcinoma (is_implicated_in) | 6.05e-04 | 25 | 197 | 3 | DOID:3459 (is_implicated_in) | |
| Disease | Hemimegalencephaly | 6.54e-04 | 6 | 197 | 2 | C0431391 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 7.09e-04 | 105 | 197 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | Colorectal cancer | 7.62e-04 | 27 | 197 | 3 | cv:C0346629 | |
| Disease | Neoplasm of the large intestine | 7.62e-04 | 27 | 197 | 3 | cv:C0009404 | |
| Disease | COLORECTAL CANCER | 7.62e-04 | 27 | 197 | 3 | 114500 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 8.95e-04 | 64 | 197 | 4 | EFO_0003888, MONDO_0005090 | |
| Disease | Rectal Carcinoma | 9.11e-04 | 7 | 197 | 2 | C0007113 | |
| Disease | Rectal Neoplasms | 9.11e-04 | 7 | 197 | 2 | C0034885 | |
| Disease | Malignant neoplasm of breast | NCOA3 GIMAP1 HPSE NEDD4 SRGAP3 NQO2 VDR FLNB KIF16B SIM1 TRAPPC8 DLL1 ELP3 EGFR MTOR MRPS23 SPEN | 9.22e-04 | 1074 | 197 | 17 | C0006142 |
| Disease | Adenocarcinoma | 1.11e-03 | 116 | 197 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 1.11e-03 | 116 | 197 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.11e-03 | 116 | 197 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.11e-03 | 116 | 197 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.11e-03 | 116 | 197 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.11e-03 | 116 | 197 | 5 | C0205641 | |
| Disease | Polydactyly | 1.15e-03 | 117 | 197 | 5 | C0152427 | |
| Disease | aspartate aminotransferase measurement | DENND2D CFAP299 OR4C3 SEPTIN3 PTPRJ PUM3 IFT80 FLNB BIN1 KIF16B MADD MTOR MAP4K5 PRKCI MYBPC3 | 1.16e-03 | 904 | 197 | 15 | EFO_0004736 |
| Disease | microcephaly (is_implicated_in) | 1.21e-03 | 8 | 197 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | gamma-glutamyl hydrolase measurement | 1.21e-03 | 8 | 197 | 2 | EFO_0801616 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.26e-03 | 32 | 197 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | eyelid sagging measurement | 1.26e-03 | 32 | 197 | 3 | EFO_0009360 | |
| Disease | colorectal cancer (is_implicated_in) | 1.34e-03 | 121 | 197 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | mean platelet volume | GALK2 RPN1 DENND2D TUBA8 JAK2 PCYOX1L PTPRJ SYK RNF145 PITPNM2 TUBA1C CAPZA1 KIF16B MAP4K5 PACSIN2 MYBPC3 | 1.43e-03 | 1020 | 197 | 16 | EFO_0004584 |
| Disease | Alzheimer disease, fasting blood glucose measurement | 1.55e-03 | 9 | 197 | 2 | EFO_0004465, MONDO_0004975 | |
| Disease | refractive error | 1.64e-03 | 326 | 197 | 8 | MONDO_0004892 | |
| Disease | reaction time measurement | MYO1G KCNH7 FIBIN SRGAP3 KCNJ3 TUBA1C APC GRIA1 ANKRD44 GIGYF2 DGKI METTL15 | 1.65e-03 | 658 | 197 | 12 | EFO_0008393 |
| Disease | Parkinson's disease (is_implicated_in) | 1.70e-03 | 76 | 197 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Malignant Neoplasms | 1.72e-03 | 128 | 197 | 5 | C0006826 | |
| Disease | Disproportionate short stature | 1.78e-03 | 77 | 197 | 4 | C0878659 | |
| Disease | risk-taking behaviour | DLGAP1 ZNF536 TMEFF2 MAGI2 KCNJ3 TRHDE AKT3 ZNF618 GRIA1 DLL1 LRPPRC DGKI METTL15 | 1.97e-03 | 764 | 197 | 13 | EFO_0008579 |
| Disease | Alcoholic Intoxication, Chronic | 2.24e-03 | 268 | 197 | 7 | C0001973 | |
| Disease | age at menarche | DLGAP1 MC4R DSCAML1 MAGI2 GABPB2 AKT3 SIM1 MADD FAM83B METTL15 GABPB1 | 2.28e-03 | 594 | 197 | 11 | EFO_0004703 |
| Disease | thrombin generation potential measurement | 2.34e-03 | 11 | 197 | 2 | EFO_0005538 | |
| Disease | response to virus | 2.34e-03 | 11 | 197 | 2 | GO_0009615 | |
| Disease | visual epilepsy (is_implicated_in) | 2.34e-03 | 11 | 197 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | neutrophil count | MYO1G RPN1 ASH1L PTGFRN ZNF491 ITPR2 JAK2 GABPB2 PMPCA PTPRJ FLNB BIN1 CAPZA1 ATF6 CD1C LNPEP MAP4K5 SBF2 GABPB1 | 2.38e-03 | 1382 | 197 | 19 | EFO_0004833 |
| Disease | ciliopathy (implicated_via_orthology) | 2.41e-03 | 40 | 197 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 20:3 measurement | 2.41e-03 | 40 | 197 | 3 | EFO_0010362 | |
| Disease | Moyamoya disease | 2.41e-03 | 40 | 197 | 3 | MONDO_0016820 | |
| Disease | Giant Cell Glioblastoma | 2.45e-03 | 84 | 197 | 4 | C0334588 | |
| Disease | Congenital small ears | 2.59e-03 | 41 | 197 | 3 | C0152423 | |
| Disease | bitter beverage consumption measurement | 2.78e-03 | 42 | 197 | 3 | EFO_0010089 | |
| Disease | high grade glioma (is_marker_for) | 2.78e-03 | 42 | 197 | 3 | DOID:3070 (is_marker_for) | |
| Disease | interferon alpha measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0006517 | |
| Disease | basal cell carcinoma (is_implicated_in) | 2.80e-03 | 12 | 197 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | Thromboembolism | 2.80e-03 | 12 | 197 | 2 | C0040038 | |
| Disease | obsolete aging | 2.80e-03 | 279 | 197 | 7 | GO_0007568 | |
| Disease | Mammary Carcinoma, Human | 2.92e-03 | 525 | 197 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.92e-03 | 525 | 197 | 10 | C1257931 | |
| Disease | Memory Loss | 2.97e-03 | 43 | 197 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 2.97e-03 | 43 | 197 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 2.97e-03 | 43 | 197 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 2.97e-03 | 43 | 197 | 3 | C0751293 | |
| Disease | Memory Disorders | 2.97e-03 | 43 | 197 | 3 | C0025261 | |
| Disease | Mammary Neoplasms | 3.00e-03 | 527 | 197 | 10 | C1458155 | |
| Disease | Malignant neoplasm of prostate | 3.00e-03 | 616 | 197 | 11 | C0376358 | |
| Disease | Prostatic Neoplasms | 3.00e-03 | 616 | 197 | 11 | C0033578 | |
| Disease | coffee consumption measurement, tea consumption measurement | 3.17e-03 | 44 | 197 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.17e-03 | 44 | 197 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Memory impairment | 3.17e-03 | 44 | 197 | 3 | C0233794 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 3.30e-03 | 13 | 197 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 3.47e-03 | 538 | 197 | 10 | C0678222 | |
| Disease | Neurodevelopmental Disorders | 3.54e-03 | 93 | 197 | 4 | C1535926 | |
| Disease | cardiovascular disease | 3.77e-03 | 457 | 197 | 9 | EFO_0000319 | |
| Disease | Squamous cell carcinoma of esophagus | 3.82e-03 | 95 | 197 | 4 | C0279626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIEKYYTRLGNDFHT | 16 | P08708 | |
| QDYKYRVSDVTKAGH | 291 | P11473 | |
| QDYLTIHKYGNAARN | 551 | Q9UKU6 | |
| RCSIVSYHGNVLYDK | 131 | Q8WTP8 | |
| DYVHVTSTEGVRAYL | 176 | Q8WVB6 | |
| KAYYNARHEASAQID | 2541 | Q9NR48 | |
| VIGNYYSLRSQHEKA | 336 | Q9UJX2 | |
| NEYVAKGLTDSIHRY | 111 | P19397 | |
| YAEYRILHARVGTAS | 311 | Q9HB65 | |
| HYQTGINFDKYDTIL | 261 | Q9NQI0 | |
| YHTNLYLSADAEKVR | 166 | Q9BXI3 | |
| HVKRYSTYDDRQLGH | 296 | Q13829 | |
| NHSEKQYIRTFVDYA | 136 | P08910 | |
| SALRAYVKDHYSNGF | 126 | P52907 | |
| ELREAYHAVVLSYGA | 121 | P22570 | |
| YAAYAVKSRVQEHPA | 326 | Q9NZJ6 | |
| HISQSYDDERKTALY | 341 | Q8WXK1 | |
| DGYHTLQYKRTAVEH | 116 | O14490 | |
| IGSHDQHAYALDIYR | 871 | Q4L235 | |
| DGIIQKNSYRYDHSV | 431 | P18850 | |
| HDAVLDNVLYARAYT | 181 | Q14565 | |
| AYSIGREQNHLYLKT | 2006 | Q8IZT6 | |
| AEKATLYHRAAVDDY | 986 | Q2TAZ0 | |
| IDRKDSYYSIHQIAQ | 116 | Q9Y4P1 | |
| VSALDYLHSGKIVYR | 256 | Q9Y243 | |
| EYVKNGQSHRAYASK | 276 | Q8NE62 | |
| YLESRSINEKDYHSR | 56 | P49759 | |
| YHLKEGQTYVGRDDA | 471 | Q96L93 | |
| ELVYHKSDGSELYTQ | 126 | Q96EV2 | |
| YNSIGDIIDHYRKEQ | 416 | P20936 | |
| VSLIDGYYRLTADAH | 366 | O60674 | |
| LRHAEASAIVEYAYN | 246 | Q15397 | |
| DEALKYYANHTAQIE | 2136 | Q14571 | |
| ALDGYNRTALHYAAE | 81 | Q9H765 | |
| KVGSQYRLEDSVTYH | 176 | P00751 | |
| QGQTRLSKYYEHVDI | 11 | Q9Y587 | |
| KEQYIHENYSRALEG | 541 | O60568 | |
| KEAVYSDKLQHYSTG | 571 | P54762 | |
| RYAVSEAAAHKYGID | 266 | O75636 | |
| VSRETLQGLYYLHSK | 116 | Q8IVH8 | |
| ASEYVYHLVIESKHG | 566 | Q12913 | |
| YQTKYEELQVTAGRH | 356 | P48668 | |
| DHSHQVRVKAYYRGD | 21 | P41743 | |
| EARALYNLGNVYHAK | 141 | P81274 | |
| SKALGAYRLARHAYD | 1006 | Q9HBG6 | |
| HYRVYDSNSQLAEAL | 591 | Q8WXG6 | |
| AYTEKGEVYFIDHNT | 311 | Q86UL8 | |
| KQDERGRSYYVDHNS | 776 | P46934 | |
| SLDHETQVKLYRAYV | 1321 | Q2M2H8 | |
| YQTKYEELQVTAGRH | 356 | P02538 | |
| VLDVTKHQLRYYDSG | 1766 | Q86WG5 | |
| KHQLRYYDSGEDTSC | 1771 | Q86WG5 | |
| LKLERDTTGYAYLNH | 216 | Q9UBC5 | |
| ERKVEVTYYHKNGST | 91 | Q9NS40 | |
| AHHYTIERELNGTYA | 61 | P43405 | |
| VEHYSYKADGLLRVL | 241 | P43405 | |
| YHSKYEELQVTVGRH | 371 | P35908 | |
| YDVKDVIEQYSAGHL | 541 | O43525 | |
| QLAGNKIYYIHTADD | 1486 | Q5SZK8 | |
| AQYGHYSTTEVLLRA | 46 | Q06547 | |
| YHSAKEAYEQLLQTE | 221 | O15550 | |
| YDVKDVIEQYSAGHL | 556 | P56696 | |
| AAYKGHTDVVRYLLE | 161 | Q9UK73 | |
| GIYTLNEHDKYNIRS | 341 | Q5T0W9 | |
| AIVHDNKDGTYAVTY | 1566 | O75369 | |
| QADFSVLHYAGKVDY | 591 | Q7Z406 | |
| LHSTEGKALYQVAYE | 271 | Q8NBM8 | |
| YQTKYEELQITAGRH | 356 | P04259 | |
| VANKEYVAYSHTGRI | 211 | Q969X5 | |
| SSHSDGAQYVKRYKG | 416 | Q5TAQ9 | |
| LANVHKAYYQRSDGS | 421 | Q01415 | |
| YTSDLHFQVSKDRYG | 251 | Q1KMD3 | |
| RHGSDSEYTEKLQQY | 586 | P54753 | |
| SSQEKQAEILEYAYH | 226 | Q9UIQ6 | |
| LGITRDETTAKHYYS | 311 | Q9P2M1 | |
| DTLQKLGAVYDVSHY | 151 | P42704 | |
| LYYSQHAVKQLEGEA | 146 | Q8N7Z2 | |
| ALYYSQHAVKQLEGE | 96 | H0YM25 | |
| ERTGYTKTYQAHAKQ | 91 | Q96MN2 | |
| SIRDKEGYNSIHYAA | 526 | Q8N8A2 | |
| ARAYRYVGHKDVVTS | 51 | Q8TC44 | |
| DGYAAHLAQLKYSHR | 1246 | Q9BZ72 | |
| NRIHTTAEKYREYEA | 31 | A6NJ78 | |
| FNYGVETHEAYKQRS | 66 | P16083 | |
| YCNYASKGTARLIEH | 86 | Q9H5V7 | |
| ENEVSTLYKGEYHRA | 211 | Q8NB16 | |
| HHYYLNGRTATKEDF | 296 | Q9Y251 | |
| YHTGTYQDRLTKLQD | 66 | Q96HR3 | |
| YETENQHYGRSLTKE | 191 | Q8NFU5 | |
| ENVYEAKSYERSVIH | 766 | Q9GZU2 | |
| EKSSVRELHIAYRYG | 166 | Q5T2D3 | |
| YNTYASAIHRTEKTG | 171 | P12034 | |
| DLSNVAGYKAIYHDL | 256 | Q9UNF0 | |
| AGYKAIYHDLEQSIR | 261 | Q9UNF0 | |
| YVREHKDNIGSQYLL | 801 | P00533 | |
| KGAHYSNEVYELAQV | 216 | Q8WWP7 | |
| TNKRYLHYAEGLQID | 731 | Q9P2H3 | |
| NEALYKLYSAAATHR | 521 | Q8WXF7 | |
| DNYTEAAYTLLLHAK | 1231 | Q14185 | |
| HDYIRAYLGDTSEAK | 1171 | Q6Y7W6 | |
| TREIQDHASQDYSKY | 96 | P29017 | |
| NRDIVSGLKYVQHTY | 116 | P52566 | |
| IAASYVKYLESAGAR | 56 | Q92820 | |
| YLESRQNYKVIGHED | 1046 | O75912 | |
| QDLHSSGRTDLKYSY | 161 | O00548 | |
| STYEELARAYEHAKL | 1806 | Q8TD84 | |
| RVYNVSQKLYAEHSL | 196 | Q5TA50 | |
| KTVYANGHQETKYRS | 1306 | Q9HC77 | |
| YSTHRLYQVLEGENK | 446 | Q68CZ6 | |
| YKYICAEHLARGTDS | 1971 | P08519 | |
| HTSNNIYEAVKYSER | 196 | Q9H9T3 | |
| KARKHGENYSVDYLT | 191 | P15586 | |
| YRLHSNASESLGKGY | 21 | P32245 | |
| VVSHNDYYAGEAKNR | 421 | Q8N7U6 | |
| AYTAYRTALSHGHQK | 131 | Q6UWF9 | |
| YQYVGKLHSDQDRGD | 71 | P55285 | |
| QKDSEAIRSQYAHYF | 416 | Q00013 | |
| KHQSISEDISQYYIG | 2921 | Q8NDH2 | |
| DVHNLDYYKKTTNGR | 641 | P22607 | |
| ELAAEIAKHVGYSYR | 441 | P42261 | |
| KLVDYDSARHHYESL | 146 | O00499 | |
| TVEGYIAYRHDQKGS | 171 | P31944 | |
| GEESYGKYLRRESHQ | 111 | Q8TAL6 | |
| VHGYFDSRQNYSEKE | 246 | Q9H4I8 | |
| VRHYNYTGKLNISAD | 26 | P21453 | |
| DSRVRATGHSYEKYN | 106 | P15086 | |
| HVARYASSVKDGSQY | 421 | Q86YQ8 | |
| YSALHKRQVGDYENV | 796 | P20273 | |
| IVGHYASYIKREANG | 386 | Q9H6A0 | |
| SQEAHKDVSYLYRFN | 71 | P15328 | |
| GSLETQEYHLYREKK | 51 | Q8N6C8 | |
| YGDVYKARNVHTGEL | 31 | Q9Y4K4 | |
| YVSGAVLALRLYEHT | 1371 | Q6ZRI0 | |
| YIVILYSLRSHSADG | 216 | Q8NH37 | |
| KVLQYYSAATEHDRS | 1771 | P42345 | |
| LLVYYLKDHTRVGAD | 461 | Q9H1H9 | |
| AQYGHYSTAEVLLRA | 46 | Q8TAK5 | |
| YHLLVRDVSKENSGY | 356 | Q9P2B2 | |
| HEDRIRAKFYSVYGS | 66 | Q9Y3D9 | |
| SGSRYEAKYLSGIAH | 96 | Q10713 | |
| RKDHGDVSNQLYACY | 406 | P15313 | |
| DHAGIKDRVYSNSIY | 231 | Q86WV6 | |
| DLQARYKAVLQEYGH | 176 | Q13049 | |
| HKDQLSYYETRGQSE | 356 | Q96M34 | |
| YAAQKYVGTHDFRNL | 211 | Q9BZE2 | |
| KDVTRETHYENYRAQ | 396 | O43236 | |
| THQISKDYGVYLEDS | 181 | Q13162 | |
| HYARTDYAENANKLE | 241 | Q9UIK5 | |
| VINLVTYRAKSHQDY | 781 | Q8IVG5 | |
| SYAEYGHFVDIRIAA | 876 | Q6P1X5 | |
| KRHYQEAYLNGHAET | 316 | Q9Y6Q9 | |
| VLYEKGRNHYTESIS | 391 | Q99519 | |
| VYYRDEIGNVSTSHL | 291 | P04843 | |
| SHRQYFDKHAYTLTG | 701 | P81133 | |
| KYEVDTSGIYHINQE | 131 | O15466 | |
| YEVKLGAHQLDSYSE | 96 | Q16651 | |
| SKLQDEANYHLYGSR | 376 | Q13546 | |
| RYDGVHFSVNDSKYI | 41 | O15047 | |
| IRERSHESYAKNYSV | 456 | Q9UL12 | |
| HRKFVDVAQSTYDYG | 541 | Q86VW0 | |
| AAVKYALSVGYRHID | 31 | P14550 | |
| HKQSLYGDYVFDTNR | 791 | P25054 | |
| ISGYIDYAHRLKTED | 126 | Q6V702 | |
| YHLRQYTEAISVGEK | 121 | Q9H9A5 | |
| AELLKYTTQEHGDYS | 391 | Q96N96 | |
| SLVYGASDSNVYRHL | 126 | P01242 | |
| KEDAANNYARGHYTI | 96 | P0DPH8 | |
| VAYHADDGKLYNGRA | 116 | Q8NCJ5 | |
| YSTYVLHERAHTGEK | 376 | Q14592 | |
| LTAYQAEGNHIKSYV | 566 | Q5T7W0 | |
| DGYIKIYDVQHANLA | 211 | Q9GZS3 | |
| ASDNRERAYEHSAYG | 136 | Q96T58 | |
| NAAISKYYIHDVSDL | 251 | O43295 | |
| STDKEEDYIRYAHGL | 201 | Q5TBB1 | |
| RYVVHYTSANGETRE | 826 | Q9UQP3 | |
| DLKEVTHNIHYETYR | 311 | Q9UH03 | |
| TYLSVADEHLRHYGN | 516 | Q9BSA4 | |
| DTHNSYAYDGNRVRK | 166 | Q5XPI4 | |
| GTLYIAARDHIYTVD | 66 | Q9H2E6 | |
| KEDAANNYARGHYTI | 96 | P0DPH7 | |
| ECGKAYRYSSQLIQH | 306 | Q6AZW8 | |
| LIYHDRTHAGEKSYE | 576 | Q96SK3 | |
| ELNASKHRIYEYVES | 196 | Q8WWY3 | |
| ATLHKYEESYGEALE | 231 | Q8N0Z6 | |
| DYVEYSRHGTVIKGQ | 396 | O95391 | |
| LASLTYQRYKAGVDD | 161 | A8MWL6 | |
| SRIGHAYVKAHQYTE | 766 | Q8NDW8 | |
| YELDLGLNHVVRKYS | 211 | Q15393 | |
| AYKSHYLLNESNRAE | 886 | Q9BZ95 | |
| YAGTQSASLKYHLER | 786 | O15090 | |
| YLTHERTHTGEKRYE | 146 | Q8N8L2 | |
| KYYVLLHDVSAGDEQ | 191 | Q9Y2L5 | |
| VNGETDKIRYYLHSE | 291 | Q6R2W3 | |
| VLESGISREKYHTYA | 76 | A0A0C4DH27 | |
| KEDAANNYARGHYTI | 96 | Q71U36 | |
| KEDAASNYARGHYTI | 96 | Q6PEY2 | |
| YKETAYVEDRGQDHN | 441 | Q9BXT5 | |
| KEDAANNYARGHYTI | 96 | P68363 | |
| DLRHVSVYGSVYAIA | 411 | Q05940 | |
| YAGHQISRDYVRSEL | 91 | Q96MT1 | |
| YELSAVLIHRGVSAY | 336 | Q86UV5 | |
| RHIRDDTGHKAYEYQ | 121 | Q8N7K0 | |
| KEDAANNYARGHYTI | 96 | Q9BQE3 | |
| VVTVGARHLSYSLDY | 101 | Q96ND8 | |
| RYASHTDTAAAYKEV | 661 | A6NCI4 | |
| KEDAANNYARGHYTV | 96 | Q9NY65 | |
| NNYARGHYTVGKESI | 101 | Q9NY65 | |
| KEDAANNYARGHYTI | 96 | P68366 | |
| HKNGTYELVYTARTE | 381 | O75382 | |
| DYGAIRNDYIVKHTK | 196 | Q9C0D4 | |
| AYTRGDLNKAHVGNY | 106 | P48549 | |
| RIKHYAGDVTYSVEG | 516 | B0I1T2 | |
| LYYREHSRAGDFSKT | 86 | O15049 | |
| HLQLHDSYDRASKVY | 206 | Q14896 |